Princeton Portfolio Strategies Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5	Closed	-$7K	–	143
2016 Q1	$7K	Hold	5	–	–	﹤0.01%	137
2015 Q4	$7K	Hold	5	–	–	﹤0.01%	135
2015 Q3	$8K	Hold	5	–	–	﹤0.01%	130
2015 Q2	$12K	Hold	5	–	–	﹤0.01%	138
2015 Q1	$14K	Hold	5	–	–	0.01%	111
2014 Q4	$16K	Hold	5	–	–	0.01%	115
2014 Q3	$17K	Hold	5	–	–	0.01%	113
2014 Q2	$18K	Hold	5	–	–	0.01%	120
2014 Q1	$19K	Hold	5	–	–	0.01%	109
2013 Q4	$18K	Sell	5 -10	-67%	-$37.9K	0.01%	111
2013 Q3	$59K	Hold	15	–	–	0.04%	108
2013 Q2	$147K	Buy	+15	New	+$166K	0.12%	105

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

Princeton Portfolio Strategies Group's FRTX Position: Q2 2016 in Review

Princeton Portfolio Strategies Group sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2016, closing a stake of 5 shares — an estimated $7K sold.

Princeton Portfolio Strategies Group first reported a position in FRTX in Q2 2013 and held it in 12 quarters. The position peaked at $147K in Q2 2013. 36 funds tracked by Wall St. Rank hold FRTX as of Q2 2016.

Princeton Portfolio Strategies Group reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Princeton Portfolio Strategies Group sold 5 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $7K.
Princeton Portfolio Strategies Group first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
Princeton Portfolio Strategies Group's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $147K in Q2 2013.
36 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Princeton Portfolio Strategies Group's 13F filing for Q2 2016, filed 15 Aug 2016.